Why the study?
Does platelet function testing predict procedural bleeding risk and guide management in patients treated with antiplatelet drugs?
Population
Patients treated with antiplatelet drugs undergoing procedures such as CABG or PCI
Design
Review
Authors
Loading...
Platelet function testing should not yet guide CABG timing or PCI decisions; leaves open its bleeding-risk utility pending large trials.
Does platelet function testing predict procedural bleeding risk and guide management in patients treated with antiplatelet drugs?
While platelet function testing shows potential for predicting procedural bleeding risk, particularly in CABG, current evidence is mixed and requires further large-scale studies to establish best practices.
Grove et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: